Lipoflex Plus Infusjonsvæske (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

The blend supplies essential amino acids that serve as substrates for protein synthesis, gluconeogenesis, and the production of neurotransmitters and immune mediators. Delivered directly into the bloodstream, the amino acids bypass the gastrointestinal tract, allowing rapid utilization by cells that need to repair tissue or sustain metabolic functions.

The prescribed dose of Lipoflex Plus Infusjonsvæske is individualized by the treating clinician based on the patient’s weight, metabolic needs, renal and hepatic function, and overall fluid balance. Healthcare professionals calculate the infusion rate and total volume to meet specific nutritional goals.

Safety data for Lipoflex Plus Infusjonsvæske in pregnancy and lactation are limited. Use is generally reserved for situations where the benefits to the mother outweigh potential risks to the fetus or infant, and it should be administered only under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Lipoflex Plus Infusjonsvæske offers a balanced profile of ten essential amino acids designed for broad clinical use. Compared with some single‑component or proprietary formulations, it provides a comprehensive amino‑acid spectrum that can reduce the need for additional supplementation, while maintaining compatibility with standard parenteral nutrition regimens.

The product should be stored at ambient temperature, below 25 °C, in its original packaging. Protect it from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze the solution, and inspect the container for any signs of damage before use.

Lipoflex Plus Infusjonsvæske is administered intravenously, typically through a central or peripheral venous catheter. The infusion rate is set by the healthcare provider according to the patient’s nutritional prescription, and the solution is usually mixed with compatible carrier fluids as part of a total parenteral nutrition (TPN) regimen.

Serious risks include severe allergic reactions such as anaphylaxis, metabolic acidosis, and significant electrolyte disturbances (for example, hyperkalemia). Patients with compromised renal or hepatic function are at higher risk and require close monitoring of laboratory parameters during therapy.

Patients with known hypersensitivity to any of the listed amino acids, those with uncontrolled electrolyte imbalances, or individuals in whom fluid overload would be hazardous (e.g., severe heart failure) should not receive the product unless a risk‑benefit assessment justifies its use.